The MarketWatch News Department was not involved in the creation of this content. -- Heart disease affects approximately 10 percent of dogs in their lifetime1 -- VETMEDIN(R) (pimobendan) from ...
How a new "breathalyzer" from the College of Veterinary Medicine could change the future of canine heart health.
Canine mitral valve disease, most commonly stemming from myxomatous degeneration, is the predominant acquired cardiac condition in dogs. This disease is characterised by progressive deterioration of ...
Mitral regurgitation is the most prevalent valvular heart disease in humans. It's also common among dogs, especially older and smaller breed dogs. In both species, the mitral valve fails to close ...
Heart disease affects approximately 10 percent of dogs in their lifetime1 VETMEDIN® (pimobendan) from Boehringer Ingelheim is the only medication approved to treat preclinical mitral valve disease in ...